EBOV GP vaccine: Phase I start

In December, Novavax will begin a single-blind, placebo-controlled, dose-escalating international Phase I trial to evaluate 3 doses of 6.5, 13, 25 or 50 Ug intramuscular EBOV GP vaccine with or withou...